BRPI0607412A2 - preparação de ação retardada em forma de péletes contra vertigem - Google Patents
preparação de ação retardada em forma de péletes contra vertigemInfo
- Publication number
- BRPI0607412A2 BRPI0607412A2 BRPI0607412-0A BRPI0607412A BRPI0607412A2 BR PI0607412 A2 BRPI0607412 A2 BR PI0607412A2 BR PI0607412 A BRPI0607412 A BR PI0607412A BR PI0607412 A2 BRPI0607412 A2 BR PI0607412A2
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- pellets
- delayed action
- vertigo
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Fireproofing Substances (AREA)
Abstract
PREPARAçãO DE AçãO RETARDADA EM FORMA DE PéLETES CONTRA VERTIGEM. A presente invenção refere-se a uma composição farmacêutica de uma preparação de ação retardada em forma de péletes, para o tratamento de vertigem seja qual for a gênese. Portanto, é descrita uma composição farmacêutica contendo cinarizina e dimenidrinato, sendo que a liberação de substâncias ativas é retardada e a preparação está presente em forma de péletes. A composição farmacêutica contém, adicionalmente, aglutinante, agente de retardamento e cargas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005014142A DE102005014142B4 (de) | 2005-03-23 | 2005-03-23 | Pelletförmige Retardzubereitung gegen Schwindel |
PCT/DE2006/000546 WO2006099864A2 (de) | 2005-03-23 | 2006-03-23 | Pelletförmige retardzubereitung enthaltend cinnarizin und dimenhydrinat gegen schwindel |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0607412A2 true BRPI0607412A2 (pt) | 2009-09-01 |
Family
ID=36732469
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0607412-0A BRPI0607412A2 (pt) | 2005-03-23 | 2006-03-23 | preparação de ação retardada em forma de péletes contra vertigem |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090298852A1 (pt) |
EP (1) | EP1874314B1 (pt) |
JP (1) | JP2008534451A (pt) |
KR (1) | KR20080003324A (pt) |
CN (1) | CN101141963B (pt) |
AT (1) | ATE477801T1 (pt) |
BR (1) | BRPI0607412A2 (pt) |
CA (1) | CA2602209A1 (pt) |
DE (2) | DE102005014142B4 (pt) |
DK (1) | DK1874314T3 (pt) |
ES (1) | ES2349996T3 (pt) |
HK (1) | HK1112404A1 (pt) |
PT (1) | PT1874314E (pt) |
RU (1) | RU2401110C2 (pt) |
WO (1) | WO2006099864A2 (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10301981A1 (de) * | 2003-01-15 | 2004-07-29 | Hennig Arzneimittel Gmbh & Co. Kg | Kombinationspräparat gegen Schwindel |
DE102010062810B4 (de) * | 2010-09-07 | 2014-03-13 | Immungenetics Ag | 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien |
DE102011075354A1 (de) | 2011-05-05 | 2012-11-08 | Hennig Arzneimittel Gmbh & Co. Kg | Arzneiform zur gezielten Freigabe von Wirkstoffen |
LT2704698T (lt) | 2011-05-05 | 2019-11-25 | Hennig Arzneimittel Gmbh&Co Kg | Vaisto forma, skirta aktyvių ingredientų kontroliuojamam atpalaidavimui |
DE102011051308A1 (de) * | 2011-06-24 | 2012-12-27 | Hennig Arzneimittel Gmbh & Co. Kg | Herstellungsverfahren und Arzneiform |
PT2938328T (pt) * | 2012-12-27 | 2023-09-26 | Hennig Arzneimittel Gmbh&Co Kg | Fármaco monolítico para a libertação modificada de uma combinação de princípios ativos |
EP2959887B1 (de) * | 2014-06-26 | 2018-11-14 | Hennig Arzneimittel GmbH&Co. Kg | Arzneimittel zur Behandlung von Schwindel verschiedener Genese |
AU2019261476B2 (en) * | 2018-04-25 | 2021-11-18 | Oncocross Co.,Ltd. | Composition for preventing and treating muscular disease |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
DE10301981A1 (de) * | 2003-01-15 | 2004-07-29 | Hennig Arzneimittel Gmbh & Co. Kg | Kombinationspräparat gegen Schwindel |
-
2005
- 2005-03-23 DE DE102005014142A patent/DE102005014142B4/de not_active Expired - Fee Related
-
2006
- 2006-03-23 JP JP2008502247A patent/JP2008534451A/ja active Pending
- 2006-03-23 PT PT06722698T patent/PT1874314E/pt unknown
- 2006-03-23 BR BRPI0607412-0A patent/BRPI0607412A2/pt not_active IP Right Cessation
- 2006-03-23 KR KR1020077022243A patent/KR20080003324A/ko active IP Right Grant
- 2006-03-23 US US11/887,025 patent/US20090298852A1/en not_active Abandoned
- 2006-03-23 ES ES06722698T patent/ES2349996T3/es active Active
- 2006-03-23 DK DK06722698.5T patent/DK1874314T3/da active
- 2006-03-23 AT AT06722698T patent/ATE477801T1/de active
- 2006-03-23 EP EP06722698A patent/EP1874314B1/de not_active Not-in-force
- 2006-03-23 CA CA002602209A patent/CA2602209A1/en not_active Abandoned
- 2006-03-23 CN CN2006800088355A patent/CN101141963B/zh not_active Expired - Fee Related
- 2006-03-23 DE DE502006007693T patent/DE502006007693D1/de active Active
- 2006-03-23 WO PCT/DE2006/000546 patent/WO2006099864A2/de active Application Filing
- 2006-03-23 RU RU2007137435/15A patent/RU2401110C2/ru not_active IP Right Cessation
-
2008
- 2008-02-21 HK HK08101931.2A patent/HK1112404A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CN101141963A (zh) | 2008-03-12 |
ATE477801T1 (de) | 2010-09-15 |
HK1112404A1 (en) | 2008-09-05 |
PT1874314E (pt) | 2010-11-15 |
CA2602209A1 (en) | 2006-09-28 |
KR20080003324A (ko) | 2008-01-07 |
DE102005014142A1 (de) | 2006-10-05 |
JP2008534451A (ja) | 2008-08-28 |
EP1874314A2 (de) | 2008-01-09 |
ES2349996T3 (es) | 2011-01-14 |
WO2006099864A2 (de) | 2006-09-28 |
DK1874314T3 (da) | 2010-11-22 |
CN101141963B (zh) | 2012-07-04 |
DE102005014142B4 (de) | 2006-11-09 |
RU2007137435A (ru) | 2009-04-27 |
DE502006007693D1 (de) | 2010-09-30 |
EP1874314B1 (de) | 2010-08-18 |
US20090298852A1 (en) | 2009-12-03 |
RU2401110C2 (ru) | 2010-10-10 |
WO2006099864A3 (de) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0607409A2 (pt) | preparação de retardo em forma de comprimidos contra vertigem | |
BRPI0607412A2 (pt) | preparação de ação retardada em forma de péletes contra vertigem | |
WO2006124047A3 (en) | Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent | |
WO2006096439A3 (en) | Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases | |
HK1126119A1 (en) | Therapeutic agent for inflammatory bowel disease comprising 2-amino-1,3- propanaediol derivative as active ingredient, and its use in manufacture of medicines for preventing or treating inflammatory bowel disease 2--13- | |
WO2007087068A3 (en) | Inhibitors of tyrosine kinases and uses thereof | |
ZA200705750B (en) | Compositions and methods for stabilizing active pharmaceutical ingredients | |
WO2009007328A3 (de) | Verwendung von homo- und copolymeren zur stabilisierung von wirkstoffformulierungen | |
BRPI1011188A2 (pt) | composições de liberação dérmica compreendendo complexos de partículas de agente ativo-fosfato de cálcio e métodos para usar as mesmas. | |
WO2007127333A3 (en) | Compositions for the treatment and prevention of eyelid swelling | |
IL219216A0 (en) | A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent | |
EP1940474A4 (en) | ALBUMIN-BASED COLLOIDAL COMPOSITION HAVING AT LEAST ONE PROTECTED THIOL ZONE, METHODS OF PREPARATION AND METHODS OF USE | |
MX2009010167A (es) | Composicion farmaceutica solida que comprende un derivado de bencimidazol-7-carboxilato y un agente para el control del ph. | |
IL191758A0 (en) | Composition with sustained release of the active ingredient, process for the preparation thereof and use thereof | |
EP1952818A4 (en) | OSTEOCLASTICIZATION PREPARATION, ORAL AGGREGATION AND PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST BONE DISEASES WITH LACTOFERRIN-CONTAINING LIPOSOME | |
GB0502787D0 (en) | Pharmaceuticlly active compounds, their manufacture, compositions containing them and their use | |
HK1112721A1 (en) | Tissue disruption treatment and composition for use thereof | |
EP2801358A3 (en) | The use of nicotine for diminishing pain in renal region in humans | |
TW200616680A (en) | Solid medical preparation | |
MX2009005578A (es) | Derivados de aminoquinazolinas con propiedades reductoras de plaquetas de la sangre. | |
WO2007002881A3 (en) | Compositions and methods of use of derivatized flavanols | |
PL1874410T3 (pl) | Odbarwiająca lub rozjaśniająca kompozycja kosmetyczna zawierająca co najmniej jedną oksazolinę jako składnik aktywny | |
GB0810227D0 (en) | Synergistic binder composition, method for making same and tablets of an active and said binder having advantages hardness and friability | |
WO2008015202A3 (en) | Anticonvulsive pharmaceutical compositions | |
HK1122731A1 (en) | Prolonged release formulation of active pharmaceutical ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 9A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2307 DE 24/03/2015. |